Airways management in SARS-COV-2 acute respiratory failure: A prospective observational multi-center studyL. Cattin, F. Ferrari, S. Mongodi, E. Pariani, G. Bettini, F. Daverio, K. Donadello, E. Polati, F. Mojoli, V. Danzi, S. De Rosa
10.1016/j.medin.2022.07.002
Med Intensiva. 2023;47:131-9
Aspergiloma y COVID-19M. Álvarez Fernández, D. Armando Meléndez, M. Aymerich de Franceschi
10.1016/j.medin.2020.07.014
Med Intensiva. 2023;47:62-3
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patientsC. Gabara, B. Solarat, P. Castro, S. Fernández, J.R. Badia, D. Toapanta, S. Schulman, J.C. Reverter, A. Soriano, J. Moisés, J. Aibar
10.1016/j.medin.2021.07.004
Med Intensiva. 2023;47:1-8
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patientsG. Moreno, M. Ruiz-Botella, I. Martín-Loeches, J. Gómez Álvarez, M. Jiménez Herrera, M. Bodí, F. Armestar, A. Marques Parra, Á. Estella, S. Trefler, R. Jorge García, J. Murcia Paya, P. Vidal Cortes, E. Díaz, R. Ferrer, A. Albaya-Moreno, L. Socias-Crespi, J.M. Bonell Goytisolo, S. Sancho Chinesta, A. Loza, L. Forcelledo Espina, J.C. Pozo Laderas, M. deAlba-Aparicio, L. Sánchez Montori, I. Vallverdú Perapoch, V. Hidalgo, V. Fraile Gutiérrez, A.M. Casamitjana Ortega, F. Martín Serrano, M. Nieto, M. Blasco Cortes, J. Marín-Corral, J. Solé-Violán, A. Rodríguez
10.1016/j.medin.2021.10.002
Med Intensiva. 2023;47:23-33
